VANCOUVER, British Columbia,
March 6, 2013 /PRNewswire/
-- Abattis Bioceuticals Corp. (the "Company" or "Abattis")
(OTC PINK: ATTBF) (CNSX: FLU), announces it has signed a letter of
intent with Crudessence Kombucha Inc. ("RISE") to acquire the
worldwide exclusive license "the License" to produce, distribute,
market and sell a Kombucha tea infused or blended with additional
nutraceutical and bioceutical formulas developed and owned by
Abattis and its subsidiaries. Under the Terms of the Agreement will
acquire "the License" in exchange for 500,000 shares of Abattis at
a deemed price of CAD $0.20 and a
running technology royalty fee to "RISE".
Rise Kombucha is a highly successful brand sold across
Canada, the purpose of the LOI is
to enable Abattis to initially bring a new brand of Cannabidiol CBD
infused probiotic functional beverages to the markets starting in
Washington and Colorado, the brand will be launched as
"Cannabucha Sun Rise™" this product will be the first
of its kind with infused Cannabidiol "CBD" with the probiotic
effects to create one of the best possible health drinks in the
world. Kombucha is a microbial culture of various bacteria and
yeast species. Fermentation of the culture in naturally sweetened
tea produces numerous organic acids such as ascetic acid, gluconic
acid, malic acid, amino acids and enzymes, and polyphenols (e.g.
catechins) that improve overall health.
Mr. Mike Withrow, Chief Executive
Officer on behalf of the Company, stated, "We are very excited to
enter into the emerging US CBD infused product markets, leading
with a Kombucha beverage which is fast growing in popularity.
Kombucha is a perfect delivery beverage for CBD's because it is a
functional probiotic drink that strengthens the immune system,
balances intestinal flora, stimulates digestion, combats stress,
and increases energy." Mr. Withrow went on to say, "With Mr.
Tim Fealey, former Executive VP of
Product Development for The Coca Cola Company and as our VP of
Product Development we are able to ensure we achieve all of the
necessary goals to make this a huge success in the markets we
address."
About Abattis Bioceuticals Corp.
Abattis Bioceuticals Corp. is a specialty biotechnology company
with capabilities through its wholly owned subsidiaries of
producing, licensing and marketing proprietary ingredients and
products containing standardized phytochemicals for sale in
Pharmaceutical, Nutraceutical, Cosmetic and Animal Nutrition
markets. The company also has a deep pipeline of proprietary
products ready for sale in high growth areas of Functional Foods
and Supplements business. For more information, visit the Company's
website at www.abattis.com.
About Crudessence and Rise Kombucha.
RISE is a young rapidly growing company committed to offering
living, sparkling tea beverages. In harmony with nature, our
kombucha not only tastes good but also is the perfect adjunct to
good health. RISE is a brand that is in sync with the evolution of
society. By combining the best in natural health and the best
scientific research available, we offer a delicious, healthy and
affordable whole food beverage.
ON BEHALF OF THE BOARD
"Michael
Withrow"
Michael Withrow, President &
CEO
Neither the CNSX Exchange nor its regulations services
accepts responsibility for the adequacy or accuracy of this
release.
Contact: Nick
Brusatore, +1-604-356-0411, nbrusatore@gmail.com
SOURCE Abattis Bioceuticals Corp.
